PYC Therapeutics Limited
PYC Therapeutics Limited, often referred to as PYC, is an innovative biotechnology company headquartered in Australia. Founded in 2017, PYC focuses on developing transformative RNA-targeted therapies for genetic disorders, positioning itself at the forefront of the biotechnology industry.
With a commitment to addressing unmet medical needs, PYC Therapeutics has made significant strides in its research and development efforts, particularly in the field of RNA therapeutics. The company’s core products, which include proprietary RNA-targeted drug candidates, are designed to offer unique solutions for conditions caused by genetic mutations.
PYC's dedication to advancing therapeutic options has garnered recognition within the industry, establishing it as a notable player in the biotechnology landscape. As it continues to expand its operational reach, PYC Therapeutics remains committed to innovation and improving patient outcomes globally.
-21 vs industry average
PYC Therapeutics Limited’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at PYC Therapeutics Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for PYC Therapeutics Limited yet.
PYC Therapeutics Limited's reported carbon emissions
PYC Therapeutics Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that PYC Therapeutics may still be in the early stages of developing a comprehensive sustainability strategy. As the industry increasingly prioritises climate action, it will be essential for PYC Therapeutics to establish measurable targets and initiatives to align with global climate goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
PYC Therapeutics Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for PYC Therapeutics Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
PYC Therapeutics Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project